Evaluation of antineoplastic effect of CAM (clarithromycin) in a mouse model inoculated with lung cancer cells
Hamada, K.; Sakamoto, M.; Mikasa, K.; Teramoto, M.; Mori, K.; Tsujimoto, M.; Maeda, K.; Konishi, M.; Sawaki, M.; Narita, N.; Kita, E.
Japanese Journal of Antibiotics 50 Suppl A: 28-31
1997
ISSN/ISBN: 0368-2781 PMID: 9597434 Document Number: 469473
Document emailed within 1 workday
Related Documents
Miyoshi, T.; Kondo, K.; Ishikura, H.; Kinoshita, H.; Matsumori, Y.; Monden, Y. 2000: SCID mouse lymphogenous metastatic model of human lung cancer constructed using orthotopic inoculation of cancer cells Anticancer Research 20(1a): 161-163Togami, K.; Chono, S.; Morimoto, K. 2012: Transport characteristics of clarithromycin, azithromycin and telithromycin, antibiotics applied for treatment of respiratory infections, in Calu-3 cell monolayers as model lung epithelial cells Die Pharmazie 67(5): 389-393
Shibuya, N.; Zou, D.T.; Hibino, S.; Ono, Y.; Shinoda, K.; Matsuda, K.; Kokubo, Y.; Takeichi, A.; Azuma, A.; Kudo, S. 2000: Effect of clarithromycin on adhesion and infiltration of cancer cells Japanese Journal of Antibiotics 53 Suppl A: 48-51
Sakamoto, M.; Mikasa, K.; Majima, T.; Konishi, M.; Maeda, K.; Yoshimoto, E.; Murakawa, K.; Takahashi, K.; Kita, E.; Narita, N. 2000: Usefulness of clarithromycin in paitents with unresectable non-small-cell lung cancer--clinical evaluation of those who survived for a long time and those succumbed in a short period Japanese Journal of Antibiotics 53 Suppl A: 56-59
Eichenberger, T.; Trachtenberg, J.; Chronis, P.; Keating, A. 1989: Synergistic effect of ketoconazole and antineoplastic agents on hormone-independent prostatic cancer cells Clinical and Investigative Medicine. Medecine Clinique et Experimentale 12(6): 363-366
Fingert, H.J.; Chen, Z.; Mizrahi, N.; Gajewski, W.H.; Bamberg, M.P.; Kradin, R.L. 1987: Rapid growth of human cancer cells in a mouse model with fibrin clot subrenal capsule assay Cancer Research 47(14): 3824-3829
Nerome, K.; Kumihashi, H.; Nerome, R.; Hiromoto, Y.; Yokota, Y.; Ueda, R.; Omoe, K.; Chiba, M. 1999: Evaluation of immune responses to inactivated influenza vaccines prepared in embryonated chicken eggs and MDCK cells in a mouse model Developments in Biological Standardization 98: 53-63; Discussion: 73-74
Marincola, F.M.; Da Pozzo, L.F.; Drucker, B.J.; Holder, W.D. 1990: Adoptive immunotherapy of human pancreatic cancer with lymphokine-activated killer cells and interleukin-2 in a nude mouse model Surgery 108(5): 919-929
Makinde, A.Y.; Luo-Owen, X.; Rizvi, A.; Crapo, J.D.; Pearlstein, R.D.; Slater, J.M.; Gridley, D.S. 2009: Effect of a metalloporphyrin antioxidant (MnTE-2-PyP) on the response of a mouse prostate cancer model to radiation Anticancer Research 29(1): 107-118
Moyes, R.B.; Kirch, H.; DeLoach, J.R. 1996: Enhanced biological activity of human recombinant interleukin 2 coupled to mouse red blood cells as evaluated using the mouse Meth a sarcoma model Biotechnology and Applied Biochemistry 23(1): 29-36
Wenzel, D.G.; Morgan, D.L. 1983: Interactions of ozone and antineoplastic drugs on rat lung fibroblasts and Walker rat carcinoma cells Research Communications in Chemical Pathology and Pharmacology 40(2): 279-287
Evans, W.K. 1997: Cost-effectiveness of gemcitabine in stage IV non-small cell lung cancer: an estimate using the Population Health Model lung cancer module Seminars in Oncology 24(2 Suppl 7: S7
Brunengo, A.M.; Massouh, E.J.; Ubogui, J.L. 1979: Protective effect in the serum of rabbits inoculated with BHK-21 cells infected with foot-and-mouth disease virus Revista Argentina de Microbiologia 11(1): 14-21
Tanpowpong, K. 2000: Nasal model and lung model machine for intranasal stent with filters efficacy evaluation Journal of the Medical Association of Thailand 83(9): 1077-1081
Nissen, N.I. 1972: Evaluation of the clinical effect of antineoplastic drugs Ugeskrift for Laeger 134(25): 1345-1346
Brooks, R.E. 1971: Ultrastructure of lung lesions produced by ingested chemicals. I. Effect of the herbicide paraquat on mouse lung Laboratory Investigation; a Journal of Technical Methods and Pathology 25(6): 536-545
Horiuchi, H.; Kawamata, H.; Furihata, T.; Omotehara, F.; Hori, H.; Shinagawa, Y.; Ohkura, Y.; Tachibana, M.; Yamazaki, T.; Ajiki, T.; Kuroda, Y.; Fujimori, T. 2004: A MEK inhibitor (U0126) markedly inhibits direct liver invasion of orthotopically inoculated human gallbladder cancer cells in nude mice Journal of Experimental and Clinical Cancer Research: Cr 23(4): 599-606
Iavorskaia, N.P. 1971: Probit-analysis in the evaluation of the selectivity of antineoplastic effect of agents Voprosy Onkologii 17(8): 90-94
Weng, W.L.; Lazo, J.S.; Gillis, C.N.; Pitt, B.R. 1990: Disposition of radioiodinated benzylguanidines in perfused rabbit lung: pharmacokinetics and effect of an organo-gold complexed antineoplastic agent Journal of Pharmacology and Experimental Therapeutics 255(1): 59-65
Kotchetkov, R.; Gröschel, B.; Gmeiner, W.H.; Krivtchik, A.A.; Trump, E.; Bitoova, M.; Cinatl, J.; Kornhuber, B.; Cinatl, J. 2000: Antineoplastic activity of a novel multimeric gemcitabine-monophosphate prodrug against thyroid cancer cells in vitro Anticancer Research 20(5a): 2915-2922